What Is the Standard of Care for Primary Mediastinal B Cell Lymphoma; R-Chop or DA-EPOCH-R? - Response to Melani Et Al

British Journal of Haematology - United Kingdom
doi 10.1111/bjh.15183
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

Wiley

Related search

What Is the Standard of Care for Primary Mediastinal B-Cell Lymphoma; R-Chop or DA-EPOCH-R?

British Journal of Haematology
Hematology
2018English

Da-Epoch-R Versus R-Chop in High Risk DLBCL Patients: Analysis of the Czech Lymphoma Study Group (Clsg)

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Primary Mediastinal Large B-Cell Lymphoma

Oncologist
Cancer ResearchMedicineOncology
2006English

Primary Mediastinal Large B-Cell Lymphoma-The Role of Mediastinal Radiation

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

Phase Ii Study of Durvalumab (Anti-Pd-L1) Combined With Either R-Chop or Lenalidomide and R-Chop in Previously Untreated, High-Risk Diffuse Large B-Cell Lymphoma

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

ROBUST: First Report of Phase III Randomized Study of Lenalidomide/R-Chop (R2 -CHOP) vs Placebo/R-Chop in Previously Untreated ABC-type Diffuse Large B-Cell Lymphoma

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Primary Mediastinal Large B-Cell Lymphoma During Pregnancy

Case Reports in Hematology
2012English

Treatment of High Risk Aggressive B Cell Lymphomas With Da Epoch R- The Austrian Experience

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

PROGNOSTIC FACTORS (PFs) IN PRIMARY MEDIASTINAL LARGE B-Cell LYMPHOMA (PMLBCL) TREATED WITH RITUXIMAB-CHOP (RCHOP) ± RADIOTHERAPY (RT)

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy